Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20726
Title: Plasma endothelin-1 and adrenomedullin are associated with coronary artery function and cardiovascular outcomes in humans.
Austin Authors: Theuerle, James D ;Farouque, Omar ;Vasanthakumar, Sheran;Patel, Sheila K ;Burrell, Louise M ;Clark, David J ;Al-Fiadh, Ali H
Affiliation: Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 2019
metadata.dc.date: 2019-04-02
Publication information: International journal of cardiology 2019; 291: 168-172
Abstract: Endothelin-1 (ET-1) is a vasoconstrictor associated with cardiovascular disease, whereas adrenomedullin (ADM) is a vasorelaxant with cardioprotective properties. We sought to determine the relationship between plasma ET-1 and ADM with coronary circulatory function and long-term major adverse cardiovascular events (MACE). Thirty-two patients undergoing coronary angiography for chest pain were recruited. Baseline plasma ET-1 and ADM levels were measured. The index of microcirculatory resistance (IMR), coronary flow mediated dilatation (cFMD) and coronary flow reserve (CFR) were measured in a non-obstructed coronary artery. Patients were assessed for MACE over a median period of 8.8 years. Plasma ET-1 levels correlated with IMR (r = 0.57; p < 0.01) and ADM levels correlated with CFR (r = 0.50; p = 0.04) and cFMD (r = 0.62; p = 0.01). After adjustment for age, gender and cardiovascular risk factors, the association between ADM and cFMD (β = 0.79; p < 0.01) and between ET-1 and IMR (β = 5.7; p = 0.01) remained significant. IMR was higher, although not statistically significant, in patients with long-term MACE (17.9 ± 5.3 vs. 13.1 ± 6.0 units; p = 0.14). In patients free of MACE, cFMD (9.3 ± 7.6 vs. 2.8 ± 5.0%; p = 0.01) and plasma ADM levels (7.6 ± 5.3 vs. 4.0 ± 1.9 pmol/L; p = 0.07) were higher. Plasma ET-1 and ADM were associated with measures of coronary microvascular and coronary conduit vessel function, respectively. Increased cFMD and elevated plasma ADM were associated with a cardioprotective effect.
URI: http://ahro.austin.org.au/austinjspui/handle/1/20726
DOI: 10.1016/j.ijcard.2019.04.008
ORCID: 0000-0002-0626-1899
0000-0003-1863-7539
PubMed URL: 30987836
Type: Journal Article
Subjects: Adrenomedullin
Coronary flow mediated dilatation
Coronary microcirculation
Endothelin
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.